Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer

Fig. 2

IGFBP-1 a, PRL b, PgR c, and ERα d mRNA levels before and after MPA treatment. PRE: MPA pretreatment; POST: 3 months after MPA treatment; NS, not significant. (*P < 0.01, ** P < 0.05). ERα, estrogen receptor-α; IGFBP-1, insulin-like growth factor-binding protein 1; MPA, medroxyprogesterone acetate; PgR, progesterone receptor

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us